Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AEMD
Aethlon Medical Inc
0.399899
0.020299 (5.35%)
Volume: 84,613
Day Range: 0.3798 - 0.40
Last Trade Time: 6:54:32 PM EDT
AEMD
Aethlon Medical Inc
0.5024
0.0024 (0.48%)
Volume: 101,457
Day Range: 0.49 - 0.5133
Last Trade Time: 7:19:09 PM EST
The Company recently contracted with NAMSA, LLC 2023 (NAMSA), www.namsa.com, a world-leading MedTech CRO offering global end-to-end development services, to direct our planned oncology study in Australia and the United States. This new clinical trial in oncology is planned to be a safety, feasibility and dose finding trial in solid tumors failing anti-PD-1 antibodies. We believe that this trial will help inform the design of future efficacy trials of our Hemopurifier in oncology. The Company plans to initiate this trial first in Australia and then in the United States. {very smart move to hire Dr. Arnold and commence trials in Australia first. The US fda is a toxic organization and everyone who knows anything about pharmaceuticals knows this but may not admit it in public}
We recently hired Lee Arnold, PhD, as our new Chief Scientific Officer. Dr. Arnold is a creative scientific leader with 36 years of accomplishments in molecularly-targeted drug discovery. After an initial eight publications in biophysics and biochemistry as an undergraduate at University of Waterloo, he earned a PhD in Organic Chemistry from University of Alberta. Dr. Arnold began his career in pharma research at Syntex, Inc. (Canada), and then joined Pfizer Inc., where he was the inventor of Tarceva® (erlotinib) for non-small cell lung cancer, or NSCLC. During his tenure at BASF/Abbott Bioresearch Center, he established medicinal & combinatorial chemistry operations, and initiated and led two multinational multidisciplinary projects in angiogenesis, ultimately leading to linifanib (ABT-869). As Vice President of Research at OSI Pharmaceuticals, Dr. Arnold and his teams discovered four oncology development candidates, including the “first-in-class” agents linsitinib (IGF-1R), and ASP7486 (TORC1/2).
Dr. Arnold also has served as Chief Scientific Officer (CSO) in a number of innovative start-up biotechnology companies. Just prior to joining Aethlon Medical, Dr. Arnold was the CSO and cofounder of Pardes Biosciences, Inc., which was established at the start of the COVID pandemic as a virtual company that discovered and advanced the oral protease inhibitor, pomotrelvir, into clinical trials for SARS-CoV2 in only 17 months. Dr. Arnold’s inventive and leadership contributions in drug discovery and development to date have resulted in an approved drug, and 16 additional development candidates, currently fueling eight clinical trials in oncology, immunology and virology. These achievements are documented in over 94 published patents and applications, and more than 39 peer-reviewed publications.
AEMD
Aethlon Medical Inc
0.6174
-0.0426 (-6.45%)
Volume: 634,599
Day Range: 0.5901 - 0.6899
Last Trade Time: 7:56:18 PM EST
I tried to tell you that. I can’t put my finger on how this company operates their business plan or why they bother to be on the Pinks, except to gain access to the liquidity and to me, if anything ever comes from their little filter, it’s gonna go through their related company, not this POS.
A very strange entity this one is, in my opinion.
yes, something not right Aethlon Medical Inc
Somehow I knew you would still be here pumping this garbage. As I said 2 years ago, go get a Fram oil filter at AutoZone and do the same thing, in my opinion
P.S. The market agrees with ME
plus they have plenty of cash and relatively small number of shares outstanding.
I'm a hold also. I'm looking forward to the cancer trials. They said "second half of 2023" in Australia.
For now though we need to get share price over $1.00 and stay there.
was a good presentation. no doubt about the efficacy of the product. it is a game changer. not what big pharma wants though... product has too much potential.
smart move though, the company going to other countries for trials like Australia and India.
I especially like them using the cro with access to international regions. India is tops on my list as they are much more independent.
Long term hold for me and attractive at this price.
Did anyone watch the presentation today.
The corruption at the FDA and CDC/NIH is pouring out and public is not happy.
Thanks Elon for transparency...the pillar of honest human endeavors.
Aethlon will survive this December tax selling month. When there is blood in the (wall)street, it is time to buy....to paraphrase Buffet and others.
And guess what,,,Athelon will clean up that mess with their purifier!
AEMD
Aethlon Medical Inc
0.30
-0.001 (-0.33%)
Volume: 355,849
Day Range: 0.30 - 0.33
Last Trade Time: 6:26:14 PM EST
unchanged AEMD
Aethlon Medical Inc
0.51
0.015 (3.03%)
Volume: 116,808
Day Range: 0.485 - 0.5084
Bid: 0.482
Ask: 0.50
Last Trade Time: 5:23:23 PM EST
Total Trades: 357
We'll see after hours, AEMD reports @ 4:15 EST. I was intrigued with the science of removing exosomes from the blood. I wonder if FRAM would be interested? :D)
Just kidding mick, GLTY
me too , lot to be had here $AEMD
AEMD
Aethlon Medical Inc
0.504
0.0262 (5.48%)
Volume: 113,930
Day Range: 0.4779 - 0.51
Bid: 0.3961
Ask: 0.5901
Last Trade Time: 7:59:08 PM EST
Total Trades: 423
I own Aethlon, bought near the high. :D(
AEMD
Aethlon Medical Inc
0.5237
-0.0577 (-9.92%)
Volume: 280,236
Day Range: 0.49 - 0.59
Bid: 0.5202
Ask: 0.5251
Last Trade Time: 12:27:26 PM EDT
Total Trades: 552
AEMD Detailed Quote
wow read M1
too cheap, so i bot a few. Any pharma that is a threat to big pharma runs into to problems with the FDA.....always. They are twin brothers in corruption. There is a new movie coming out about The Real Dr. Fauci. It is a block buster no kidding. I saw the first half on Rumble...next half comes out tomorrow.
These Fauci NIH Infectious Disease guys have many patents...those who worked at the higher eschelons of NIH and receive royalties from BP who then sell the drugs. It is a direct conflict of interest which is why Fauci refuses to show his royalty income and from what BP companies, In the movie too is a brief interview and show clips from Tony Browns Journal with Dr. Null showing the AIDS patients with blood work that they cured in the clinic over in Italy. Tony Brown...Award Winning best program on PBS was canceled not long after the show. He used a heat treating and filtering the blood and ozone treatments to cure all who were in his trial. This may be where Aethlon picked up on some of these treatments ie the Hemopurifier. They are getting near the time of recognition and this will be a blockbuster too that will save many lives come the next pandemic which is on the horizon. $AEMD$
too cheap, so i bot a few. Any pharma that is a threat to big pharma runs into to problems with the FDA.....always. They are twin brothers in corruption. There is a new movie coming out about The Real Dr. Fauci. It is a block buster no kidding. I saw the first half on Rumble...next half comes out tomorrow.
These Fauci NIH Infectious Disease guys have many patents...those who worked at the higher eschelons of NIH and receive royalties from BP who then sell the drugs. It is a direct conflict of interest which is why Fauci refuses to show his royalty income and from what BP companies, In the movie too is a brief interview and show clips from Tony Browns Journal with Dr. Null showing the AIDS patients with blood work that they cured in the clinic over in Italy. Tony Brown...Award Winning best program on PBS was canceled not long after the show. He used a heat treating and filtering the blood and ozone treatments to cure all who were in his trial. This may be where Aethlon picked up on some of these treatments ie the Hemopurifier. They are getting near the time of recognition and this will be a blockbuster too that will save many lives come the next pandemic which is on the horizon. $AEMD$
AEMD
Aethlon Medical Inc
0.5725
-0.0319 (-5.28%)
Volume: 93,365
Day Range: 0.5701 - 0.604
Bid: 0.4726
Ask: 0.703
Last Trade Time: 7:47:46 PM EDT
Total Trades: 370
AEMD Detailed Quote
unreal pps share $Aethlon med
AEMD
Aethlon Medical Inc
1.01
0.0189 (1.91%)
Volume: 350,855
Day Range: 0.9601 - 1.03
Bid: 0.98
Ask: 1.02
Last Trade Time: 6:47:27 PM EDT
Total Trades: 1,12
yes, way back in the late eighties or early nineties a doctor was curing HIV patients with something very similar which I believed this morphed into. Saw the doctor with 3 AIDS patients with him on Tony Browns Journal TV program. He had to take them to Italy to get it done. It was amazing. It wasn't long and his top ranked show got canceled. I believe this was on the PBS channel.
THANKS, 'C-11", Dude!!!
2 groups gave Aethlon medical a "buy" rating with a average price of $6.50
I HEAR ya, Dude! And the CRICKETS, too!
The good news is the 23 million they've raised to date Is ample money to manufacture enough hemopurifiers for the clinical trials they want to do
Well it looks like we're back to crickets lol...
AEMD: Hope so!! (As the REST of all those TEMPORARY morning gappers are crashing --- as they SHOULD!)
Bottom line? GO-GO-GO-AEMD=$$$$=FUN-FUN-FUN (Hope???) I LIKE what they are trying to do with their anti-COVID, "MULTI-VARIANTS", inter alia., DRUGS!
I'm re-checking my 'Markets Scanner' (see below), right now!
looks like she is running now.
newbie to the AEMD board. I bought in this morning. Sounds like a good medical device. Has anyone thought of it before?
Nuke
wow, I …….
….
see that now! i was busy going back to md (from va) to get my belongings as we got flooded out of the mgm grand casino hotel in Md (DC area). had to go all the way back to va and wait until they call me to say if at least one elev was working. it was a mess.
i posted it on youtube. if you google “mgm grand MD hotel flood” you will see it and my story of what all happened (in the detailed description just under and right side of the video, click the little down arrow. it was very scary.
Large pop AH's all of a sudden MPV stocks spiked
Nice pop in AH! Glad I bought today.
Going now weeee
Pelosi landing @ 10:20e in Taiwan. China promising strong response to visit. Stay vigilant, market could flush depending on what the response is...
Pre-market trading is heavy. Last check $1.47
AEMD yes
Aethlon Medical Inc
1.47
0.47 (47.00%)
Volume: 76,192,967
Day Range: 1.37 - 1.72
Bid: 1.46
Ask: 1.47
Last Trade Time: 7:58:40 PM EDT
Total Trades: 149,375
AEMD Detailed Quote
Decent AH spike. Also check out AMTD stock. It's spiked over 200% in AH. I believe there's still another 300% run from $6.00
Yep, holding gains well
$AEMD will be the best performing monkeypox stock of the day/week. It has the lowest market cap, and the volume has been 10x it's average all last week but just now finally getting price action to the upside. Apes are all over this and they have an FDA approved product.
4:02 AM · Aug 1, 2022
Followers
|
226
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
18434
|
Created
|
11/19/04
|
Type
|
Free
|
Moderators |
At Aethlon Medical, we are a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses,
the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies.
The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure cloaks these targets from immune detection.
At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc.,
a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.
Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical,
is focused on the discovery of exosomal biomarker candidates to diagnose and monitor life-threatening diseases.
The proprietary Enzyme-Linked Lectin-Specific Assay (ELLSA™) serves as a platform to isolate exosomal biomarkers from a wide-range of bodily fluids.
In preliminary studies, ELLSA™ demonstrated the ability to isolate exosomes from urine, which resulted in high-sensitivity detection of HIV-infection.
Specific to neurological disorders, Exosome Sciences discovered TauSome™, an exosomal biomarker that may be the first non-invasive candidate to
detect Chronic Traumatic Encephalopathy (CTE) in living individuals. In a study of former National Football League (NFL) players,
TauSome levels were found to be significantly higher as compared to athlete control subjects who participated in non-contact sports.
TauSome levels also correlated with cognitive decline based standardized tests of memory and psychomotor speed. Visit www.exosomesciences.com for additional details.
Time Magazine named the Hemopurifier® a "Top 25 Invention" and a "Remarkable Advance in Healthcare" based on its use in treating Ebola virus.
Emerging pathogens pose a significant threat to mankind. Of the hundreds of viral pathogens known to be infectious to man, only a few are addressed with
proven antiviral drug or vaccine therapies. Beyond the looming threat of bioterrorism, a proliferation of international travel, urban crowding and global warming
is expected to accelerate the emergence of future pandemics. In response, the U.S. Department of Health and Human Services (HHS) has established an initiative
to support platform technology medical countermeasures with broad-spectrum capabilities. Based on preclinical studies and human treatment experiences, the Aethlon Hemopurifier® defines this initiative.
To date, Hemopurifier therapy has been administered to individuals infected with Ebola virus, Hepatitis C virus (HCV) and the Human Immunodeficiency virus (HIV).
In the case of Ebola, a remarkable response to a single administration of Hemopurifier therapy (comatose physician with multiple organ failure at the time), led to
Time Magazine naming the Hemopurifier to be one of the "Top 25 Inventions" as well as one of the "Eleven Most Remarkable Advances in Healthcare."
Beyond human treatment experiences, pre-clinical Hemopurifier studies have validated the broad-spectrum capture of numerous viral threats.
These include: Chikungunya, Dengue and West Nile virus, as well as Vaccinia and Monkey pox, which serve as models for human Smallpox infection.
Specific to pandemic influenza threats, Aethlon has validated the capture of H5N1 avian flu, H1N1 swine flu, and the reconstructed 1918 influenza virus,
which represents a model for the strain of influenza that killed an estimated 50 million victims in 1918 and 1919. In vitro studies of other viral threats are ongoing.
https://coronavirus.jhu.edu/map.html
================================================================================================================================================================================
================================================================================================================================================================================
================================================================================================================================================================================
*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |